ABSTRACT: New mixed cationic liposomes based on L-α-phosphatidylcholine and dihexadecylmethylhydroxyethylammonium bromide (DHDHAB) were designed to overcome the BBB crossing by using the intranasal route. Synthesis and self-assembly of DHDHAB were 3
acetylcholinesterase by implementing a non-invasive approach, via the "nose-brain" pathway.
Introduction
Intranasal route remains one of the elective non-invasiveness routes for the treatment of brain diseases [1] . It is highly appealing in clinical settings due to rapid central action of drug. This expands drug efficiency in emergency treatment [2] . The nasal mucosa allows direct delivery of drugs to the brain bypassing the blood brain barrier (BBB). It avoids hepatic clearance and drug degradation by liver enzymes, and therefore, increases the effect of neurotherapy [3] .
Applicability of intranasal route is limited by lipophilicity and molecular weight of drugs [4] .
New formulations to maximize the concentration of drugs and new devices for intranasal administration have been developed [5] . To improve drug transfer to the brain and to prolong the residence time of drug in the nasal cavity, several strategies may be employed, namely the use of (i) permeation enhancers, muco-adhesive and heat sensitive gels, or (ii) nano-sized drug carriers.
Colloidal nanosized carriers are especially important for brain delivery and targeting of drugs for treatment of neurodegenerative diseases [6] . Intranasal delivery to the brain by using nanosized particles can be carried out for small molecules, as well as for proteins, hormones, vaccines, DNA, etc [7] [8] [9] [10] . The main strategy to improve drug delivery to the brain by intranasal administration is the modification of nanoparticles by absorption and permeation enhancers. For that purpose, surfactants, bile salts, cyclodextrins, derivatives of chitosan, arginine, lactoferrin, have already been proposed [11] [12] [13] [14] [15] [16] . Liposomes are well-known universal nano-carriers. Their surface can be easily modified to provide them with multiple functions [17] . This has already been demonstrated for improvement of intranasal delivery [18] of rivastigmine [19, 20] , donepezil [21] , zolmitriptan [22] .
The present work was aimed at using intranasal drug delivery as an alternative route to crossing of the BBB by using cationic liposomes as drug carriers. Cationic liposomes usually consist of natural neutral phospholipids and positively charged lipids [23] . Cationic liposomes deserve attention and further development since the ability of nanoparticles to penetrate the nasal mucus is obviously dependent not only on the size, but also, primarily, on the surface charge of particles [24] . In addition, the positive charge of liposomes plays an important role in the in vitro processes of interaction with cells epithelium [25] and as a mucosal adjuvant [8, 26] . We applied the cationic liposome intranasal drug delivery approach in the treatment of organophosphorus poisoning. Organophosphorus agents (OPs) are highly toxic chemicals used as pesticides; some of them are banned chemical warfare agents. OPs represent a global chemical threat for both armed forces and civilian populations [27] . The acute toxicity of OPs results from inhibition of acetylcholinesterase (AChE). Acute poisoning causes death due to respiratory failure, seizures and irreversible brain damage. The current post-exposure treatment is to administer a combination of an AChE reactivator, atropine as an anticholinergic drug, and an anticonvulsant to prevent irreversible brain damage [27, 28] . However, current AChE reactivators (quaternary oximes) are unable to reactivate phosphylated AChE in the central nervous system because they do not cross significantly the BBB [29] . Different strategies have been implemented for allowing these reactivators to cross the BBB [30] . In particular, non-quaternary oximes capable of crossing the BBB were synthesized. However, none of newly synthesized molecules has been developed so far [31, 32] . New trends have emerged with the development of nanotechnology and new delivery systems, making quaternary oximes capable of crossing the BBB [33] [34] [35] . The intranasal route has also been successfully tested for administration of drugs against OP poisoning. For example, intranasal midazolam led to cessation of soman-induced seizures [36] .
Intranasal administration of oximes has been considered as an alternative way for bypassing the BBB. Indeed, intranasal administration of obidoxime contributed to a reduction of brain damage and death of rats after poisoning by paraoxon [37] . Also, aerosolized butyrylcholinesterase, as a bioscavenger, was successful for protection of macaque lungs against volatile OPs [38] ; rapid intranasal delivery of enzymes to the brain indicates that this route could be used for protection of CNS against toxicants [39] , including OPs. Our present results validate the intranasal brain delivery approach using cationic liposome as drug carriers. wetted to a set depth. A contact angle θ of 0° (cos θ = 1) with liquids was formed. The surface tension was calculated from the measured force. Between two surface tension measurements, the platinum ring and the platinum plate were cleaned with Ultra-purified water, then soaked in ethanol for 5-7 min, rinsed again with Ultra-purified water, and finally flame-dried; iii) the bubble pressure method. In this method air gas bubble was blown at constant rate through a capillary tube submerged into the surfactant solutions. The surface tension was calculated by the Laplace equation (∆Pmax = 2γ/r, where γ is the surface tension, and r is the capillary tip radius, using the measured maximum pressure difference ∆Pmax; iv) the drop weight (stalagmometric) method [40] . For this purpose, several drops of liquid leaked out of the glass capillary of the stalagmometer were weighed. The surface tension was determined from the number of drops leaking out; v) The pendant drop shape analysis technique [41, 42] is one of the most accurate methods to measure surface tension; it has many advantages over other methods [43, 44] Droplets of aqueous dispersions of the samples were carefully placed on mica surface. The AFM imaging was performed after water evaporation.
Materials and methods
2.5. Small-angle neutron scattering. SANS measurements on DHDHAB solutions were performed on the Yellow Submarine instrument operating at the Budapest Research Reactor [45] . The surfactant was dissolved in D2O at concentrations 0.6 and 1.21 mg/ml, filled in planar quartz cells of 2 mm path length, and measured at 37± 0.5°C, over a q-range of 0.08 -3 nm -1 .
The scattering curves were modeled by form factors of unilamellar vesicles, using the software SasView.
2.6. Solubilization study. Solubilization study of the dye (Orange OT) was performed by adding an excess of crystalline Orange OT to the cationic surfactant solutions. These solutions were allowed to equilibrate for about 48 h at 35°C, followed by filtration, and the absorbance was measured at 495 nm using a spectrophotometer Specord 250 Plus (Analytik Jena AG, Germany).
Quartz cuvettes (1 cm cell path) containing sample were used. Solubilization capacity of associates (S), which corresponds to the number of moles of dye solubilized per mole of surfactant was determined according to equation 1 [46, 47] 
where В is the slope of dye absorbance as a function of surfactant concentration above CAC and εext the extinction coefficient of Orange OT (εext = 18720 M -1 cm -1 ). 2.10. Morphology and particle size analysis. The mean particle size, zeta potential and polydispersity index of nanoparticles were determined by dynamic light scattering (DLS) measurements, using the Malvern Instrument Zetasizer Nano (Worcestershire, UK) at neutral pH (close to 7). Measured autocorrelation functions were analyzed by Malvern DTS software, applying the second-order cumulant expansion methods. The effective hydrodynamic radius (RH)
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was calculated according to the Einstein-Stokes equation D=kBT/6πηRH, where D is the diffusion coefficient, kB the Boltzmann constant, T the absolute temperature, and η the viscosity. The diffusion coefficient was measured at least three times for each sample. Five measurements of electrophoretic mobilities on each sample were converted into zeta potential by using the Smoluchowski relationship [49] : ζ=μη/ε, where ζ is the zeta potential, η the dynamic viscosity of the fluid, μ the particle mobility and ε the dielectric constant. All samples were diluted with ultra-purified water to suitable concentration and analyzed in triplicate. Analysis of the optimal formulation was performed by fluorescence microscopy (Leica DM IRBE/Leica TCS SP2) to confirm the presence of liposomes, to verify the shape of the particles, and the absence of aggregation.
Encapsulation efficiency and loading capacity. Encapsulation efficiency (EE, %) and
loading capacity (LC, %) were assessed for samples containing 2-PAM and Rhodamine B. These parameters were determined indirectly by filtration/centrifugation technique, measuring free 2-PAM (non-encapsulated) by spectrophotometry. A volume of 0. (10th-30th min) was calculated. Sample without substrate was used as a blank. All measurements for each sample were done in triplicate. AChE activity was expressed in relation to the amount of total protein, which was determined by the Bradford method. Data were analyzed using Origin 8 software and expressed as the mean ± SEM. Statistical analysis was performed using the Mann-Whitney test. P< 0.05 were considered statistically significant.
Results and discussion
In the present work, two cationic surfactants dihexadecyldimethylammonium bromide (DHDAB) and dihexadecylmethylhydroxyethylammonium bromide (DHDHAB) (Fig. 1) were used for modification of liposomes. Our interest focused on the properties of cationic surfactants with double, long-chains due to the fact that these surfactants are synthetic vesicle-forming amphiphiles capable of self-assembling spontaneously as giant uni-lamellar vesicles [50] [51] [52] .
Properties and dissolution of surfactants strongly depend on temperature, the chain length of alkyl radicals and the type of counter ions [53] . Not enough attention has been paid to the influence of structure of polar head-group of such cationic surfactants on their properties. In this work main attention is paid to the effect of hydroxyl group in polar head-group of cationic surfactants with double, hexadecyl chains.
Figure 1. Structures of cationic surfactants dihexadecyldimethylammonium bromide (DHDAB)
and dihexadecylmethylhydroxyethylammonium bromide (DHDHAB), hydrophobic dye (Orange OT) and fluorophore probes (Pyrene, Rhodamine B) and AChE reactivator (2-PAM).
Self-assembly and solubilization properties of cationic surfactants
Self-assembly of cationic surfactants was investigated by fluorescence, tensiometry, spectrophotometry and dynamic light scattering at 35°C. To determine the critical association concentration (CAC) of DHDAB and DHDHAB a technique with pyrene as fluorophore probe was used [54, 55] , which involved the analysis of the intensity of pyrene peaks at 373 nm (I1) and 384 nm (I3) (Fig 1S, Supplementary material) . The ratio of the intensity of the first and third peaks (I1/I3) indicates the effect of microenvironmental polarity on pyrene fluorescence. The value (I1/I3) is decreasing with increasing surfactant concentration (Fig. 2a) . This indicates the onset of surfactant aggregation and transfer of pyrene from the water phase to a nonpolar area of aggregates. After that value (I1/I3) remains unchanged. The obtained CACs for DHDAB and DHDHAB are similar, close to 0.025 mM.
The formation of associates at low concentrations was confirmed by solubilization of hydrophobic dye (Orange OT) (Fig 2b) . The increase in optical density of Orange OT in cationic surfactant solutions was observed above the CAC1. This is due to solubilization of the dye in the hydrophobic area of surfactants associates. It should be noted that such kind of surfactants (dioctadecyldimethylammonium bromide) were also shown to be effective solubilizer /or colloidal stabilizer for the hydrophobic drug miconazole [56] . The CAC1s for both DHDAB and DHDHAB are 0.01 mM, which is close to the CAC1s determined by fluorescence. The solubilization capacity, determined by equation 1, is 0.06 and 0.22 for DHDAB and for DHDHAB, respectively. These values are 4 and 14 times, respectively, higher than the solubilization capacity of the classical surfactant CTAB.
Measurements of surface activity of DHDHAB at air-water interface using different techniques are presented in Fig. 2c . The decrease in surface tension (γ, mN . m -1 ) is observed with increasing the surfactant concentration. It can be seen in Fig. 2c that the different techniques showed consistent results: the surface tension is reduced only at high concentration (close to 10 mM). A similar effect was observed for dioctadecyldimethylammonium bromide (DODAB) by Feitosa and Brown [57] . Critical concentration attributed to spontaneous formation of vesicles which was detected by optical spectroscopy and fluorescence at lower concentrations was not observed by tensiometry. It appears that physical and morphological properties, and CAC of double-tail cationic surfactant depend not only on concentration, solvent conditions, and the presence of additives, but also the sample preparation protocol and the history of temperature treatment [58, 59] . For example, the CAC of DHDAB determined by Tucker was 0.01 mM [60] However, the CAC value found by Nagarajan is lower (0.0034 mM) [61] . Lower CAC (close to 0.0001 mM) were also determined using a linear relationship between log(CAC) and the number of carbon atoms in the dialkyl chain (n) [62] and CAC of DDAB [63] [64] [65] . These strongly different Size (hydrodynamic diameter) of DHDAB and DHDHAB associates was determined by dynamic light scattering at different surfactant concentrations. The size of nanoparticles about 500 nm was observed for DHDAB concentration ≥CAC1 (Fig 2S) . The zeta potential of particles was + 60±2 mV, the polydispersity index was 0.5±0.02. All parameters did not change with increasing DHDAB concentration (Table 1S ). In the case of DHDHAB, two different size distribution patterns were observed depending on the surfactant concentration. Population of 200 nm occurs at concentrations ≥ CAC1, while two populations, 30 nm and 200 nm were observed at DHDHAB concentrations ≥ 18 mM (Fig. 3S , Table 1S The structure of the DHDHAB associates was further analyzed by small-angle neutron scattering (SANS) [66] . The scattering curves show the characteristic shape of flat structures (within the resolution range of the observation window 0.1-10 nm), which can be identified as large unilamellar vesicles (Fig. 3) . Small micelles, even if present, could not be detected due to their much weaker scattering signal.
In model fitting, the vesicle diameter and polydispersity was fixed at values 60 nm and 0.2, provided by light scattering, since the whole vesicle shape cannot be resolved at the given resolution limit. Model fitting gave membrane thickness of 4.14±0.08 nm and 4.13±0.5 nm for 1 and 2 mM DHDHAB solutions, respectively, which are in accord with the size of the surfactant molecule. The above presented results show that addition of hydroxyl group to the structure of the head group of surfactants with double hexyl chains can make a significant contribution both to self-assembly and solubilization properties of the investigated cationic surfactant dihexadecylmethylhydroxyethylammonium bromide.
Antimicrobial activity and hemolysis of DHDHAB
Determination of cytotoxicity or cell viability remains the most frequent test used as proof of biocompatibility of nanoparticles. It was reported that cytotoxicity of cationic liposomes composed of phosphatidylcholines and dialkyldimethylammonium bromide is increased with increasing surfactant concentration and their hydrophobic chain lengths [67] . Such kind of nanoformulations was recommended for topical therapy [68] . Cationic surfactants with double, long-chains exhibited antimicrobial properties [69] . It was confirmed that the determining factor of the antifungal action of cationic surfactants is not cell lysis, but a change in the cell surface from negative to positive charge [70] . Antimicrobial activity of DHDHAB surfactant is presented in Table 1 . It is obvious that the DHDHAB surfactant is very effective against grampositive bacteria Staphylococcus aureus (MIC=7.8 μg . mL -1 ) and Bacillus cereus (MIC=7.8 μg . mL -1 ). In order to provide evidence of biocompatibility of cationic surfactant formulations we investigated their action on hemolysis. The hemolytic action of DHDHAB surfactant on human erythrocytes is less than 10% in the concentration range used for liposomes surface modification. 
Preparation and characterization cationic DHDHAB vesicles and cationic mixed Ph/DHDHAB liposomes
Initially, the liposome preparation technique was developed using natural, commercially Table 2 . The same liposome preparation technique was used for the preparation of DHDHAB cationic vesicles. The morphology and size of prepared DHDHAB cationic vesicles were investigated by atomic force microscopy. Small nanoparticles of spherical-ellipsoidal shape were observed. Nanoparticle diameter is 50 nm and their elevation is about 1-2 nm (Fig. 4) AFM results are comparable with properties measured by DLS ( The conversion to intensity, number and volume-averaged distribution highlights different sizes The release of 2-PAM (90%) from the cationic Ph/DHDHAB liposomes takes three hours. It is three times slower than in the case of an aqueous solution.
Intranasal administration of the fluorescent-labeled cationic liposomes
To confirm the uptake of cationic Ph/DHDHAB liposomes into the brain tissue, cerebral cortex slices were analyzed by fluorescence microscopy (Fig. 6 ). Free rhodamine B was used as control.
Physico-chemical characteristics of cationic mixed Ph/DHDHAB liposomes with included fluorescent probe (Rhodamine B) are presented in Table 2 (form. № 9). Encapsulation of Rhodamine B did not change both size and charge of cationic liposomes. EE (%) and LC (%) parameters determined from equations 2 and 3 are 98±1% and 1.4±0.02%, respectively. In Fig. 6 it is clearly seen that the greatest absorption of rhodamine B in brain occurs through the nasal route. 
Reactivation of Brain AChE in Vivo
To test the in vivo efficacy of 2-PAM-loaded cationic Ph/DHDHAB liposomes against OPs, we used a rat model for OP toxicity using the organophosphate paraoxon (POX) as acetylcholinesterase inhibitor. After 1 h of poisoning by 0.8 × LD50 of POX (600 mg/kg, ip), brain samples were collected and AChE activity was analyzed. One hour after administration, this sub-lethal dose of POX (600 mg/kg, ip) resulted in 83.5 ± 4% inhibition of AChE in the brain ( Figure 7 ). One hour after POX (600 mg/kg, ip), 2-PAM-loaded cationic liposomes were administered intranasally at the dose of 7 mg/kg. One hour after administration of 2-PAM-loaded cationic liposomes, activity of AChE was analyzed. It was previously found that intranasal administration of free 2-PAM (10 mg per animal) was ineffective in reducing paraoxon-mediated AChE inactivation in rat brain homogenates [37] , whereas 2-PAM−liposomes reactivated 12 ± 1% of brain AChE (Figure 7 ). For substantial increase of AChE reactivation, more effective oximes could be used. However, gain in AChE reactivation level will certainly be obtained with 2-PAM by optimizing cationic surfactant formulations. 
Conclusions
The bioavailability of rhodamine B-loaded cationic liposomes to the brain when delivered by intranasal route was shown to be higher than when administered intravenously. 2-PAM-loaded cationic liposomes (the dose of 2-PAM was 7 mg/kg) intranasally administered to rat challenged with paraoxon (0.8 × LD50) were shown to reactivate central AChE (12%). This study provides evidence that reactivation of central AChE can be achieved by a non-invasive approach, i.e. to deliver oxime-loaded cationic liposomes to the brain via the "nose-brain" pathway. 
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